# PEACE 1 (NCT01957436)

> A Phase III Study for Patients With Metastatic Hormone-naïve Prostate Cancer

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT01957436
- Phase: PHASE3
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: UNICANCER
- Conditions: Metastatic Prostate Cancer
- Interventions: abiraterone acetate; radiotherapy; Androgen Deprivation Therapy; Docetaxel
- Enrollment: 1173
- Primary outcome: Survival
- Primary outcome: Survival

## Preliminary discovery

Commentary in our index that names this trial so far. Final coverage is set when the report is built.

- Bluesky threads: 8

## Order

Focused, $750, price fixed at order: https://www.erudio.com/contact?report=peace-1-nct01957436

## Free preview

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT01957436", "email": "<work email>"}; the inbox owner confirms by the emailed link.